The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.

Oncotarget · 2018 · PMC5945524 · PMID 29755696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

(2016), where a cohort of 355 patients was studied and using Cox regression analysis revealed that PCa patients with high PCAT-14 expression have better outcomes and are significantly associated with better prostate cancer specific survival (PSS), metastasis free survival (MFS), biochemical relapse-free survival (BRFS), with borderline significance for OS [ 92 ].

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.